-
Product Insights
NewNet Present Value Model: Enanta Pharmaceuticals Inc’s EDP-514
Empower your strategies with our Net Present Value Model: Enanta Pharmaceuticals Inc's EDP-514 report and make more profitable business decisions. Evaluating the value of drugs can be complex, involving a deep understanding of the drug, the current market and expected cash flows, expenses, and success rates at each stage of development. Fortunately, GlobalData simplifies this process with meticulously crafted, high-value, risk-adjusted NPV models that incorporate extensive drug intelligence.
-
Product Insights
Galicia Wind Farm-EDP, Spain
Galicia Wind Farm-EDP is proposed to be built in Galicia, Spain. The project is at the permitting stage. Empower your strategies with our Galicia Wind Farm-EDP report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays. Certain sections of the report may be removed or altered based on data availability and relevance. Reasons...
-
Product Insights
NewNet Present Value Model: Enanta Pharmaceuticals Inc’s EDP-938
Determining the value of drugs is a complicated practice and requires a deep knowledge of the drug itself, the current market, and knowledge of expected cash inflows, outflows, and potential success rates for each stage of drug development. GlobalData has done all of this work for you, Drugs Intelligence database to create high-value, risk-adjusted NPV models.
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – EDP-938 in Respiratory Syncytial Virus (RSV) Infections
How likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData's proprietary machine learning algorithms developed using over 10 years of historical data. EDP-938 in Respiratory Syncytial Virus (RSV) Infections Drug Details: EP-938 is under development for the...
-
Thematic Analysis
NewPower M&A Deals, Q1 2024 – Top Themes – Thematic Intelligence
This report analyzes the disruptive themes that have driven M&A activity in Q1 2024 in the Power Sector
-
Product Insights
Tahivilla – EDP
Tahivilla - EDP is an Onshore Wind project located in Andalusia, Spain. The project is owned by EDP Renovaveis SA and was developed by Desarrollos Eolicos De Tarifa S.A.. The project came online in 1999. Empower your strategies with our Tahivilla - EDP report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays....
-
Product Insights
EDP Solar PV Park
EDP Solar PV Park is a solar PV project located in United Kingdom. The project is owned by EDP Renewables Canada Ltd and is developed by EDP Renewables Canada Ltd; Vento Ludens Ltd. The project is at the permitting stage. Empower your strategies with our EDP Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of...
-
Product Insights
EDP-Bani Solar PV Park
EDP-Bani Solar PV Park is a solar PV project located in Peravia, Dominican Republic. The project is owned and being developed by EDP Energias Renovables Dominicana SA. The project is at the permitting stage. Empower your strategies with our EDP-Bani Solar PV Park report and make more profitable business decisions. Note: This is an on-demand report that will be delivered upon request. The report will be delivered within 2 to 3 business day of the purchase, excluding weekends and holidays....
-
Product Insights
NewNet Present Value Model: Evelo Biosciences Inc’s EDP-1815
Empower your strategies with our Net Present Value Model: Evelo Biosciences Inc's EDP-1815 report and make more profitable business decisions.Evaluating the value of drugs can be complex, involving a deep understanding of the drug, the current market and expected cash flows, expenses, and success rates at each stage of development. Fortunately, GlobalData simplifies this process with meticulously crafted, high-value, risk-adjusted NPV models that incorporate extensive drug intelligence.
-
Product Insights
NewNet Present Value Model: Enanta Pharmaceuticals Inc’s EDP-305
Empower your strategies with our Net Present Value Model: Enanta Pharmaceuticals Inc's EDP-305 report and make more profitable business decisions. Evaluating the value of drugs can be complex, involving a deep understanding of the drug, the current market and expected cash flows, expenses, and success rates at each stage of development. Fortunately, GlobalData simplifies this process with meticulously crafted, high-value, risk-adjusted NPV models that incorporate extensive drug intelligence.